DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 1838677
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1838677
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 18, 2029 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
➤ Sign Up | Apr 18, 2029 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
➤ Sign Up | Dec 20, 2025 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
➤ Sign Up | Dec 20, 2025 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |